HARTWICK COLLEGE WINS APPROVAL FOR 1ST MASTER’S DEGREE

DR. CEACAREANU TO LEAD EFFORT

HARTWICK COLLEGE

WINS APPROVAL FOR

1ST MASTER’S DEGREE

TBRM Graduates Will Turn Science

Into Practical Healthcare Advances

Dr. Alice C. Ceacareanu

ONEONTA – Hartwick College today announced it has received approval for its first-ever master’s degree: in Translational Biomedical Research Management (TBRM), training post-graduate students to take basic science and turn it into ideas aimed at advancing healthcare.

The state Education Department has approved the addition of this master of science program.  It will be administered mostly online, and is slated to begin this fall.

The college also announced that Dr. Alice C. Ceacareanu has joined the college, effective immediately, as the TBRM program director.

“Every institution of higher education has the responsibility to assess, from time to time, how best to meet the needs of learners as they navigate emerging, expanding and maturing industries,” said Hartwick President Margaret L. Drugovich.

The new master’s will prepare enrollees “to make pivotal contributions to the growing biomedical and bio-pharmaceutical industry. This program will both launch and advance careers, providing new opportunities for professional success,” Drugovich said.

The TBRM program is cohort-style: groups of students will start and progress through the program together.

The two-year curriculum includes four semesters of traditional study, and experiential training via internships and clinical trials in the summer. Coursework will focus on epidemiology, biostatistics and informatics, and molecular genetics and personalized medicine.

The new program is ideal for students with bachelor’s degrees in the natural/social sciences or health professions, those with good oral and written communication skills, and who hold entry-level professional positions in clinical/applied research and development, the college said in announcing the innovation today.

The program is also for those with advanced professional degrees (e.g.,  doctorate in business, nursing, or public health). TBRM students may not necessarily plan to pursue a doctoral degree, however.

Ceacareanu joins the college from Buffalo, where she is founder and president of ROAKETIN, Inc., a full-service healthcare consultancy, as well as a part-time oncology pharmacist. Previously, she served as an assistant professor of pharmacy practice and adjunct professor of pharmaceutical sciences for the University of Buffalo.

For nine years, she served also as an oncology clinical pharmacist at the Roswell Park Cancer Institute in Buffalo.

Ceacareanu earned a Ph.D. in biology from the University of Bucharest and a Pharm.D. from the University of Tennessee Health Science Center at Memphis.

Employment projections for TBRM-related positions are strong. According to Indeed.com, over 25,000 job openings required expertise in clinical outcomes management as of in January 2019. Pharmacovigilance competency was listed in 10,000+ job openings on Monster.com.

In New York State alone, there is a projected 15.8 percent growth in jobs in professional, scientific, and technical services in 2010-20, and 16.8 percent projected growth in the field in the Mohawk Valley Region, which includes Hartwick College.

For more information on the new TBRM master’s degree program, visit the department website [https://www.hartwick.edu/academics/translational-biomedical-research-management/] or reach out directly at TBRM@hartwick.edu or (607) 431-4404.


Leave a Reply

Your email address will not be published.